Fred Hutchinson Cancer Center
Seattle, Washington, United States
Purpose
to support an efficacy trial of a candidate HIV vaccine in the Republic of South Africa to determine if this vaccine can improve upon the modest efficacy results obtained with a similar vaccine in the “RV144” trial conducted in Thailand.
Division
Global Health
Date
July 2016
Region Served
GLOBAL
Committed amount
$52,170,860
Grant topic
HIV
Duration (months)
65
Grantee location
Seattle, Washington, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.